Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RenovoRx Inc.

Delivering diagnostic and therapeutic fluids directly to the pancreas

This article was originally published in Start Up

Executive Summary

Pancreatic cancer is currently the fourth leading cause of cancer death in the US, and it is primarily treated with systemic drugs that have limited ability to penetrate the pancreas. RenovoRx Inc. has developed an endovascular catheter that enables targeted delivery of either diagnostic or therapeutic fluids directly to the pancreas.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT037867

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel